Literature DB >> 6135334

Vaccinia virus in postvaccinal encephalitis.

E B Gurvich, I S Vilesova.   

Abstract

Results of virological examination of 239 samples taken from 84 children with neurological complications after smallpox vaccination are described. In postvaccinal encephalitis, vaccinia virus was isolated from blood, cerebrospinal fluid and pharyngeal secretions of 23 out of 40 children (57.5%) as well as from autopsy specimens sampled between 10-35 days after vaccination. During the acute period of disease, virus was detected in 17 out of 31 (54.2%) cerebrospinal fluid specimens. In 3 postvaccinal encephalitis cases the virus was present in brain and in a case of encephalomyelitis--in the spinal cord. These results confirmed the participation of vaccinia virus in the pathogenesis of postvaccinal encephalitis. The pathogenicity of vaccinia virus may be manifested only under a changed reactivity of the vaccinated host.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135334

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  7 in total

1.  Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.

Authors:  Sangeetha Vijaysri; Garilyn Jentarra; Michael C Heck; Andrew A Mercer; Colin J McInnes; Bertram L Jacobs
Journal:  Vaccine       Date:  2007-12-04       Impact factor: 3.641

2.  A mouse-based assay for the pre-clinical neurovirulence assessment of vaccinia virus-based smallpox vaccines.

Authors:  Cheryl X Zhang; Christian Sauder; Tahir Malik; Steven A Rubin
Journal:  Biologicals       Date:  2009-11-06       Impact factor: 1.856

3.  Encephalitis after secondary smallpox vaccination.

Authors:  Vlada V Melekhin; Kevin L Karem; Inger K Damon; Karen C Bloch
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

4.  Metabolic studies on vaccinia-virus-infected oligodendrocytes in brain cell cultures.

Authors:  C F Beranek; N Herschkowitz
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

5.  Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.

Authors:  Lili Deng; Jun Fan; Yuedi Ding; Jue Zhang; Bin Zhou; Yi Zhang; Biao Huang
Journal:  Oncotarget       Date:  2017-06-20

Review 6.  ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.

Authors:  Thomas P Monath; Joseph R Caldwell; Wolfgang Mundt; Joan Fusco; Casey S Johnson; Mark Buller; Jian Liu; Bridget Gardner; Greg Downing; Paul S Blum; Tracy Kemp; Richard Nichols; Richard Weltzin
Journal:  Int J Infect Dis       Date:  2004-10       Impact factor: 3.623

Review 7.  Acute disseminated encephalomyelitis: clinical and pathogenesis features.

Authors:  Farshid Noorbakhsh; Richard T Johnson; Derek Emery; Christopher Power
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.